2,221
Views
27
CrossRef citations to date
0
Altmetric
REVIEW: RADIOTHERAPY

Stereotactic body radiation therapy for early-stage hepatocellular carcinoma – a systematic review on outcome

, , , , , , , & show all
Pages 1706-1713 | Received 08 May 2019, Accepted 15 Aug 2019, Published online: 29 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Huimei Zhang, Na Chang, Tiantian Han, Shaodi Ma, Guangbo Qu, Haixia Liu, Chenyu Sun, Ce Cheng, Qin Zhou & Yehuan Sun. (2021) Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for hepatocellular carcinoma: a meta-analysis. Future Oncology 17:30, pages 4027-4040.
Read now
Hanna Rahbek Mortensen, Gerda Elisabeth Villadsen, Esben Schjødt Worm & Britta Weber. (2021) Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience. Scandinavian Journal of Gastroenterology 56:3, pages 259-265.
Read now

Articles from other publishers (25)

Michael J. Gutman, Lucas M. Serra, Matthew Koshy & Rohan R. Katipally. (2024) SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know. Seminars in Interventional Radiology 41:01, pages 001-010.
Crossref
Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, Eunji Kim, Jin-Kyu Kang, Won Il Jang, Ji Eun Moon, Isaure Roquette, Xavier Mirabel, Tomoki Kimura, Masayuki Ueno, Ting-Shi Su, Alison C. Tree, Matthias Guckenberger, Simon S. Lo, Marta Scorsetti, Ben J. Slotman, Rupesh Kotecha, Arjun Sahgal, Alexander V. Louie & Mi-Sook Kim. (2024) Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines. International Journal of Radiation Oncology*Biology*Physics 118:2, pages 337-351.
Crossref
A. M. Maher, M. Shanker, H. Y. H. Liu, Y. Lee, D. Leggett, P. Hodgkinson, D. Pryor & K. A. Stuart. (2024) Comparison of outcomes following surgical resection, percutaneous ablation or stereotactic body radiation therapy in early‐stage, solitary and small (≤3 cm) treatment‐naïve hepatocellular carcinoma. Cancer Medicine 13:3.
Crossref
Claire Beckers, Martin Pruschy & Irene Vetrugno. (2024) Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities. Seminars in Cancer Biology 98, pages 19-30.
Crossref
L.-Q. Li, T.-S. Su, Q.-Y. Wu, Z.-T. Lin & S.-X. Liang. (2023) Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions – A Systematic Review and Network Meta-analysis. Clinical Oncology 35:10, pages 652-664.
Crossref
Bingqi Guo, Kevin Stephans, Neil Woody, Alexander Antolak, Mojtaba Moazzezi & Ping Xia. (2023) Online verification of breath‐hold reproducibility using kV‐triggered imaging for liver stereotactic body radiation therapy. Journal of Applied Clinical Medical Physics 24:9.
Crossref
Zhi-wen Liang, Meng-lan Zhai, Biao Tu, Xin Nie, Xiao-hui Zhu, Jun-ping Cheng, Guo-quan Li, Dan-dan Yu, Tao Zhang & Sheng Zhang. (2023) Comprehensive Treatment Uncertainty Analysis and PTV Margin Estimation for Fiducial Tracking in Robotic Liver Stereotactic Body Radiation Therapy. Current Medical Science 43:3, pages 572-578.
Crossref
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi & David M. Liu. (2023) Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 115, pages 102526.
Crossref
Gouling Zhan, Honghua Peng, Lehong Zhou, Long Jin, Xueyi Xie, Yu He, Xuan Wang, Zhangyan Du & Peiguo Cao. (2023) A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort. Frontiers in Endocrinology 14.
Crossref
Takashi Mizowaki. (2022) SABR for primary renal cell carcinoma: single-fraction or multiple-fraction?. The Lancet Oncology 23:12, pages 1476-1477.
Crossref
Kee Fong Loo, Richard J Woodman, Damjana Bogatic, Vidyaleha Chandran, Kate Muller, Mohamed Asif Chinnaratha, John Bate, Kirsty Campbell, Matthew Maddison, Sumudu Narayana, Hien Le, David Pryor & Alan Wigg. (2022) High rates of treatment stage migration for early hepatocellular carcinoma and association with adverse outcomes: An Australian multicenter study. JGH Open 6:9, pages 599-606.
Crossref
Isaure Roquette, Emilie Bogart, Thomas Lacornerie, Massih Ningarhari, Jean-Emmanuel Bibault, Marie-Cecile Le Deley, Eric F. Lartigau, David Pasquier & Xavier Mirabel. (2022) Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety. Cancers 14:16, pages 3892.
Crossref
Yanyan Long, Yan Liang, Shujie Li, Jing Guo, Ying Wang, Yan Luo & Yongzhong Wu. (2021) Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies. Radiation Oncology 16:1.
Crossref
Mihir D. Shanker, Pereshin Moodaley, Wei Soon, Howard Y. Liu, Yoo Young Lee & David I. Pryor. (2021) Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes. Journal of Medical Imaging and Radiation Oncology 65:7, pages 956-968.
Crossref
Yong Huang, Peng Chu & Guangjian Bao. (2021) Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis. Digestive Diseases and Sciences 66:11, pages 3916-3928.
Crossref
Brittany R. Derynda, Casey L. Liveringhouse, John M. Bryant & Stephen A. Rosenberg. (2021) MR-Guided Radiation Therapy for Oligometastatic Malignancies. Applied Radiation Oncology, pages 25-32.
Crossref
John S Lubel, Stuart K Roberts, Simone I Strasser, Alexander J Thompson, Jennifer Philip, Mark Goodwin, Stephen Clarke, Darrell HG Crawford, Miriam T Levy & Nick Shackel. (2020) Australian recommendations for the management of hepatocellular carcinoma: a consensus statement. Medical Journal of Australia 214:10, pages 475-483.
Crossref
Howard Yu‐hao Liu, Yoo‐young Dominique Lee, Swetha Sridharan, Ee Siang Choong, Hien Le, Wei Wang, Richard Khor, Julie Chu, Andrew Oar, Rebekah Mott, Joanne Smart, Trish Jenkins, Nigel Anderson, Shamira Cross, Kee Fong Loo, Alan Wigg, Katherine Stuart & David Pryor. (2021) Stereotactic body radiotherapy in the management of hepatocellular carcinoma: An Australian multi‐institutional patterns of practice review. Journal of Medical Imaging and Radiation Oncology 65:3, pages 365-373.
Crossref
Michael Heller, Neehar D. Parikh, Nicholas Fidelman & Dawn Owen. (2021) Frontiers of therapy for hepatocellular carcinoma. Abdominal Radiology.
Crossref
Takuji Torimura & Hideki Iwamoto. (2021) Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects. Clinical and Molecular Hepatology 27:2, pages 236-245.
Crossref
Mihir D Shanker, Howard Y Liu, Yoo Young Lee, Katherine A Stuart, Elizabeth E Powell, Alan Wigg & David I Pryor. (2020) Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium. Journal of Gastroenterology and Hepatology 36:4, pages 873-884.
Crossref
Elizabeth Brown, Erika Muscat, Patrick O’Connor, Howard Liu, Yoo‐Young Lee & David Pryor. (2020) Intrafraction cone beam computed tomography verification of breath hold during liver stereotactic radiation therapy. Journal of Medical Radiation Sciences 68:1, pages 52-59.
Crossref
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez & Ángela Matías-Pérez. (2021) Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination. Cancers 13:2, pages 192.
Crossref
Dima Mahmoud, Mohammed A. Mohammed, Youssef Zeidan & Ali Shamseddine. 2021. Liver Cancer in the Middle East. Liver Cancer in the Middle East 189 200 .
Bin Qiu, Abudureyimujiang Aili, Lixiang Xue, Ping Jiang & Junjie Wang. (2020) Advances in Radiobiology of Stereotactic Ablative Radiotherapy. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.